abstract |
The present invention provides compounds of formula (I) useful for the treatment of diseases or conditions mediated by glucokinase (GLK), such as type 2 diabetes: Embedded image [Wherein R 1 , R 2 , R 3 , n, and m are as described in the specification], or a salt, solvate, or prodrug thereof. The invention also relates to a process for the preparation of compounds of formula (I) and their use as pharmaceuticals in the treatment of diseases mediated by glucokinase. |